Cipla
Priti Suryawanshi currently serves as Business Unit Head at Cipla since November 2024, and has extensive experience in sales and marketing leadership roles at Abbott from January 2015. During tenure at Abbott, responsibilities included leading the Marketing function for the Metabolics Business Unit, achieving significant recognition for products such as Thyronorm, and managing the Neuroportfolio for the CNS Division. Previous experience includes roles as Cluster Head of Marketing at Dr. Reddy's Laboratories, Product Manager for sanofi-aventis, and Product Executive at Sun Pharmaceutical Industries Ltd, contributing to major brand growths in neuropsychiatry and CNS segments. Priti has received several awards for marketing excellence throughout the career. Educational background encompasses a variety of prestigious programs including a Digital Marketing degree from the Indian Institute of Management Ahmedabad, a certification in Digital Performance Marketing from the Indian School of Business, and a degree in Design Thinking and Innovation from Harvard Business School, among others.
This person is not in the org chart
This person is not in any teams
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.